Hai-Ning Du, Ian M Fingerman, Scott D Briggs
Index: Genes Dev. 22(20) , 2786-98, (2008)
Full Text: HTML
Set2-mediated H3 K36 methylation is an important histone modification on chromatin during transcription elongation. Although Set2 associates with the phosphorylated C-terminal domain (CTD) of RNA polymerase II (RNAPII), the mechanism of Set2 binding to chromatin and subsequent exertion of its methyltransferase activity is relatively uncharacterized. We identified a critical lysine residue in histone H4 that is needed for interaction with Set2 and proper H3 K36 di- and trimethylation. We also determined that the N terminus of Set2 contains a histone H4 interaction motif that allows Set2 to bind histone H4 and nucleosomes. A Set2 mutant lacking the histone H4 interaction motif is able to bind to the phosphorylated CTD of RNAPII and associate with gene-specific loci but is defective for H3 K36 di- and trimethylation. In addition, this Set2 mutant shows increased H4 acetylation and resistance to 6-Azauracil. Overall, our study defines a new interaction between Set2 and histone H4 that mediates trans-histone regulation of H3 K36 methylation, which is needed for the preventative maintenance and integrity of the genome.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
6-Azauracil
CAS:461-89-2 |
C3H3N3O2 |
Rad9 interacts with Aft1 to facilitate genome surveillance i...
2014-11-10 [Nucleic Acids Res. 42(20) , 12650-67, (2014)] |
Overruling the energy gap law: fast triplet formation in 6-a...
2010-12-28 [Phys. Chem. Chem. Phys. 12(48) , 15665-71, (2010)] |
Separable functions of the fission yeast Spt5 carboxyl-termi...
2010-05-01 [Mol. Cell. Biol. 30(10) , 2353-64, (2010)] |
TFIIS is required for the balanced expression of the genes e...
2012-08-01 [Nucleic Acids Res. 40(14) , 6508-19, (2012)] |
Comprehensive structural studies of 2',3'-difluorinated nucl...
2008-07-16 [J. Am. Chem. Soc. 130(28) , 9048-57, (2008)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved